Abstract Title: currently loading...

information currently loading...

close
Loading ... please wait
timer Loading ... please wait

Free Paper Session 27: AMD V Session

Date/Time: | Room:

Back to Previous

Title

Theme

12:00:00 L. Wang Germany Efficacy of novel small moleculebased NLRP3 inhibitors in retinal pigment epithelial cells
12:06:00 C. Skevas Germany Surgical management of acute submacular hemorrhage (ASH) due to wet age related macular degeneration (wAMD): A direct comparison between three surgical methods: Pneumatic displacement with or without vitrectomy in combination with subretinal or intr
12:12:00 C. Turksever Switzerland A retrospective pilot study assessing the vessel density in nAMD after longterm antiVEGF treatment and compared to recently started antiVEGF treatment
12:18:00 A. Leys Belgium Omega3 and Vitamin D blood serum dosage in a population with moderate to high risk of AMD determined by S.T.A.R.S questionnaire
12:24:00 K. Hatz Switzerland Longterm safety and real life efficacy outcomes after combined stereotactic radiotherapy and treatandextend antiVEGF treatment for neovascular AMD
12:30:00 T. van Rijssen Netherlands Clinical characteristics and outcome in chronic central serous chorioretinopathy with focal versus extensive abnormalities
12:36:00 T. Krohne Germany Ranibizumab in pigment epithelial tears secondary to agerelated macular degeneration; a prospective study (the RIP Study)
12:42:00 W. C. Wu Taiwan Effectiveness and safety of repeated ranibizumab 0.5 mg injections in Taiwanese patients newly diagnosed with neovascular age-related macular degeneration: 12-month real-life outcomes from the RACER study
12:48:00 Y. Subhi Denmark Inflammaging in polypoidal choroidal vasculopathy and neovascular agerelated macular degeneration
12:54:00 R. Serra Italy Longterm progression of naïve quiescent choroidal neovascularization in intermediate agerelated macular degeneration, by multimodal imaging and optical coherence tomography angiography
13:00:00 G. Neri Italy CD93 is a potential new target for CNV treatment
13:06:00 S. Thiele Germany Longitudinal analysis and prognostic value of outer retinal layer intensities by SDOCT in eyes with agerelated macular degeneration
13:12:00 B. Eldem Turkey Registry of AMD In Turkish population (REGAIN): Patient demographics and treatment approaches in neovascular age related macular degeneration (nAMD)
13:18:00 R. Hamilton United Kingdom A comparison of the anatomical efficacy of brolucizumab and aflibercept in neovascular agerelated macular degeneration (nAMD): an analysis of Weeks 12–16 in the HAWK and HARRIER studies

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved